CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-27 | Hagen Heidi Director | Option exercise · Restricted Stock Unit | −2,600 | 0 | ||
| 2023-04-27 | Rubino Alan L Director | Option exercise | +2,600 | 17,594 | ||
| 2023-04-27 | Rubino Alan L Director | Option exercise · Restricted Stock Unit | −2,600 | 0 | ||
| 2023-04-25 | Rubino Alan L Director | Option exercise | +3,000 | $10.60 | $32K | 14,994 |
| 2023-04-25 | Rubino Alan L Director | Option exercise · Stock Option (Right to Buy) | +3,000 | 0 | ||
| 2023-03-01 | ZERBE ROBERT L MD Director | Option exercise | +3,000 | $10.60 | $32K | 34,795 |
| 2023-03-01 | ZERBE ROBERT L MD Director | Option exercise · Stock Option (Right to Buy) | −3,000 | 0 | ||
| 2023-02-19 | Halpin Michael Chief Operating Officer | Option exercise | +3,825 | 18,589 | ||
| 2023-02-19 | Halpin Michael Chief Operating Officer | Shares withheld for taxes | −1,868 | $29.82 | $56K | 16,721 |
| 2023-02-19 | Halpin Michael Chief Operating Officer | Option exercise · Restricted Stock Unit | −3,825 | 4,613 | ||
| 2023-02-19 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +1,750 | 53,164 | ||
| 2023-02-19 | Hopper Jonathan Mark Chief Medical Officer | Shares withheld for taxes | −752 | $29.82 | $22K | 52,412 |
| 2023-02-19 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Restricted Stock Unit | −1,750 | 3,500 | ||
| 2023-02-19 | Flynn Sean C. SVP, General Counsel | Option exercise | +1,750 | 7,008 | ||
| 2023-02-19 | Flynn Sean C. SVP, General Counsel | Shares withheld for taxes | −832 | $29.82 | $25K | 6,176 |
| 2023-02-19 | Flynn Sean C. SVP, General Counsel | Option exercise · Restricted Stock Unit | −1,750 | 3,500 | ||
| 2023-02-19 | Colangelo Dominick President and CEO | Shares withheld for taxes | −4,143 | $29.82 | $124K | 175,808 |
| 2023-02-19 | Colangelo Dominick President and CEO | Option exercise | +8,938 | 179,951 | ||
| 2023-02-19 | Colangelo Dominick President and CEO | Option exercise · Restricted Stock Unit | −8,938 | 17,875 | ||
| 2023-02-18 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise | +419 | 1,094 |
Page 37 of 75 · 1,497 trades